DNA and associated macromolecular components in anaerobic bacteria and protozoa (DNA)

DNA and associated macromolecular components in anaerobic bacteria and protozoa serve as the primary pharmacological target for nitroimidazole antibiotics (DrugBank). In the low-redox environment characteristic of anaerobic metabolism, these drugs undergo reductive activation by electron transport proteins like ferredoxin (StatPearls). This process generates highly reactive nitroso-free radicals and other short-lived intermediates that bind covalently to DNA, causing extensive strand breakage and destabilization of the helical structure. The resulting damage inhibits nucleic acid synthesis and leads to rapid cell death in the target organisms (PubMed: 10471191). This mechanism is highly selective because aerobic host cells do not possess the low-redox potential required to activate the drugs. Consequently, this target is pivotal in the treatment of infections caused by anaerobic bacteria such as Bacteroides and Clostridium, as well as protozoal parasites like Giardia and Trichomonas (NIH: PMC1074380).

Other names

Bacterial DNAProtozoal DNAGenomic DNADeoxyribonucleic acid

Nitroimidazole drugs are reduced by low-redox-potential electron transport proteins (such as ferredoxin) in anaerobic organisms, forming reactive intermediates that cause DNA strand breakage and destabilization of the helical structure, leading to cell death (DrugBank DB00916; StatPearls).